> “We will return our undivided attention to our miniLab platform,” writes Holmes of the new device she unveiled in early August at the American Association for Clinical Chemistry’s convention in Philadelphia. She added that “our ultimate goal is to commercialize miniaturized, automated laboratories capable of small-volume sample testing, with an emphasis on vulnerable patient populations, including oncology, pediatrics, and intensive care.”
This woman needs to steer far, far away from anything in the medical field for a LONG time. If she does end up back in that field, she needs to be way behind the scenes. Not presenting at a conference.
Sadly I think she would do great in the field. "Oh look she managed to raise all this money and start a company based on bogus results. We clearly need her on our team. She can deliver!". I guess it depends how you view the field and their ethics and business perspective.
Associated Press, March 14, 2018:
"Under an agreement with the Securities and Exchange Commission on Wednesday, Holmes is barred from serving as an officer or director of a public company for 10 years. The SEC said it will pursue its case against the president of the company, Ramesh "Sunny" Balwani, in federal district court in the Northern District of California."
Any public company.
[1]: https://uk.reuters.com/article/uk-lehman-fiveyear-people/you...
[1] Just to be clear, 'fake it till you make it' does not require deception. If you're up front about what you're doing with the people paying you, and are following the law, there is nothing wrong with doing things that don't scale.